Порівняння методів
Переглядайте обрані методи поруч; рядки з відмінностями підсвічено.
| Експериментальний дизайн та аналіз залежності «доза-відповідь»× | Фармакокінетична компартментна модель× | |
|---|---|---|
| Галузь≠ | Планування експерименту | Фармакометрика |
| Родина≠ | Hypothesis test | Regression model |
| Рік появи≠ | 1994 | 1982 |
| Автор методу≠ | Classical pharmacology; formalized by ICH E4 (1994) and Ritz et al. (2015) | Gibaldi & Perrier |
| Тип≠ | Nonlinear curve fitting and monotone contrast testing | Deterministic ODE-based pharmacokinetic model |
| Основоположне джерело≠ | Ritz, C., Baty, F., Streibig, J. C., & Gerhard, D. (2015). Dose-Response Analysis Using R. PLOS ONE, 10(12), e0146021. DOI ↗ | Gibaldi, M., & Perrier, D. (1982). Pharmacokinetics (2nd ed.). Marcel Dekker. ISBN: 978-0-8247-1042-2 |
| Інші назви≠ | dose-response analysis, dose-response curve, Doz-Yanıt Tasarımı ve Analizi (Dose-Response), ED50 analysis | Mammillary Compartment Model, Multi-Compartment PK Model, Compartmental Analysis, Farmakokinetik Kompartman Modeli |
| Пов'язані≠ | 4 | 3 |
| Підсумок≠ | Dose-response design is a framework for planning and analysing experiments that characterise the relationship between the amount of a stimulus — such as a drug dose or a chemical concentration — and the magnitude of a biological or physiological response. Formalised in regulatory guidance by the ICH E4 guideline (1994) and extensively developed in the statistical literature by Ritz et al. (2015), the framework covers experiment design, four-parameter and five-parameter logistic curve fitting, key benchmark estimates (ED50/EC50, NOAEL, LOAEL), and monotone trend testing via the Williams procedure. | The pharmacokinetic compartment model represents the body as one or more hypothetical compartments interconnected by first-order rate processes, describing how a drug is absorbed, distributed, and eliminated over time. Systematized by Gibaldi and Perrier in 1982, these models use ordinary differential equations to characterize plasma concentration-time profiles. They are the cornerstone of drug development, dosage regimen design, and regulatory submission pharmacokinetic analyses. |
| ScholarGateНабір даних ↗ |
|
|